Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

山 東 威 高 集 團 醫 用 高 分 子 製 品 股 份 有 限 公 司 Shandong Weigao Group Medical Polymer Company Limited *

(a joint stock limited company incorporated in the People's Republic of China with limited liability)

(Stock Code: 1066)

FURTHER DELAY IN DESPATCH OF CIRCULAR IN RELATION TO MAJOR AND DISCLOSEABLE TRANSACTIONS

Reference is made to the announcement (the "Proposed Transaction Announcement") of Shandong Weigao Group Medical Polymer Company Limited (the "Company") dated 15 June 2016 in relation to, among others, the Proposed Transaction and the announcements (the "Delay Announcements", together with the Proposed Transaction Announcement, the "Announcements") of the Company dated 6 July 2016, 28 July 2016 and 18 August 2016, respectively, in relation to the delay in despatch of the Circular. Capitalised terms used herein shall have the same meanings as defined in the Announcements unless the context requires otherwise.

As disclosed in the Delay Announcement dated 18 August 2016, the Company expected to despatch the Circular containing, among other things, further details of the Proposed Transaction, a letter from the independent board committee of the Company and a letter from the independent financial adviser of the Company together with a notice convening the EGM on or before 30 September 2016.

As additional time is required to finalise certain information in the Circular, it is expected that the despatch of the Circular will be further postponed to a date falling on or before 23 October 2016.

By Order of the Board

Shandong Weigao Group Medical Polymer Company Limited Zhang Hua Wei

Chairman

Weihai, Shandong, the PRC, 29 September 2016

As at the date of this announcement, the Board comprises: Mr. Zhang Hua Wei (Executive Director)

Mr. Wang Yi (Executive Director)

Mr. Gong Jian Bo (Executive Director)

Mr. Xia Lie Bo (Executive Director)

Mrs. Zhou Shu Hua (Non-executive Director)

Mr. Lo Wai Hung (Independent non-executive Director)

Mr. Li Jia Miao (Independent non-executive Director)

Mrs. Fu Ming Zhong (Independent non-executive Director)

Mrs. Wang Jin Xia (Independent non-executive Director)

* For illustration purpose only

Shandong Weigao Group Medical Polymer Co. Ltd. published this content on 29 September 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 30 September 2016 00:23:08 UTC.

Original documenthttp://115.28.24.216/upload/pdf/model_1475193486.pdf

Public permalinkhttp://www.publicnow.com/view/9268A380D5FEA22DCCFA42FF21A0FFFAEAFF0B23